What is the role of endobronchial (through the airways) biopsy in pediatric asthma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Endobronchial biopsy is not routinely recommended for diagnosing or managing pediatric asthma. This invasive procedure is rarely indicated in children with asthma as the diagnosis is typically made through clinical history, physical examination, pulmonary function testing, and response to bronchodilator therapy 1. The decision to perform bronchoscopy, including endobronchial biopsy, in children should always be made on an individual basis after consideration of the patient’s history, physical examination, and the results of previous diagnostic tests 1.

Indications for Endobronchial Biopsy

Endobronchial biopsy may be considered in select cases with atypical presentations, severe therapy-resistant asthma, or when alternative diagnoses need to be excluded 1. The evaluation of airways obstruction, which may involve the upper or lower airway or both, is a common indication for flexible bronchoscopy in children, but this does not typically involve endobronchial biopsy unless specific conditions are suspected that require tissue sampling 1.

Risks and Considerations

When performed, endobronchial biopsy allows direct visualization and sampling of airway tissue to assess inflammation patterns, structural changes, and cellular components. However, the procedure requires general anesthesia in children and carries risks including bleeding, pneumothorax, and airway trauma 1.

Alternative Approaches

Most children with asthma can be effectively diagnosed and managed with less invasive approaches, including spirometry, exhaled nitric oxide measurements, and therapeutic trials of asthma medications. The information gained from biopsies in pediatric asthma is primarily used in research settings to understand disease mechanisms rather than for routine clinical management 1.

Clinical Decision Making

In clinical practice, the role of endobronchial biopsy in pediatric asthma is limited to very specific situations where the benefits outweigh the risks. Given the invasive nature of the procedure and the availability of less invasive diagnostic tools, endobronchial biopsy should only be considered when absolutely necessary and after thorough evaluation of the patient's condition.

From the Research

Role of Endobronchial Biopsy in Pediatric Asthma

  • Endobronchial biopsy is a diagnostic tool used to assess airway inflammation and remodeling in pediatric asthma 2, 3, 4, 5, 6
  • The procedure involves obtaining a tissue sample from the bronchial wall, which can help identify the underlying causes of asthma symptoms and guide treatment decisions 3, 5
  • Studies have shown that endobronchial biopsy can be used to characterize airway inflammation and remodeling in pediatric asthma, including the presence of eosinophils, mast cells, and lymphocytes 4, 6
  • The results of endobronchial biopsy can be correlated with clinical symptoms and other diagnostic tests, such as spirometry and exhaled nitric oxide, to provide a comprehensive understanding of the disease 3, 4

Indications and Techniques

  • Endobronchial biopsy is typically performed in children with severe or difficult-to-control asthma, or in those with suspected airway remodeling or other complications 2, 5
  • The procedure is usually performed under general anesthesia using a flexible or rigid bronchoscope, and requires a working channel of at least 2 mm in diameter to obtain adequate tissue samples 5
  • The main contraindication to endobronchial biopsy is bleeding disorders, and informed consent and institutional ethical approval are required for research purposes 5

Findings and Implications

  • Studies have shown that pediatric severe asthma is characterized by eosinophilia and remodeling, but not necessarily by the presence of T(H)2 cytokines 4
  • Endobronchial biopsy can help identify specific patterns of airway inflammation and remodeling, which can inform treatment decisions and guide the development of personalized therapies 2, 3
  • The use of endobronchial biopsy in pediatric asthma research has the potential to improve our understanding of the disease and lead to the development of more effective treatments 2, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Severe pediatric asthma endotypes: current limits and future perspectives.

Expert review of respiratory medicine, 2023

Research

Endobronchial biopsy: a guide for asthma therapy selection in the era of bronchial thermoplasty.

The Journal of asthma : official journal of the Association for the Care of Asthma, 2013

Research

Endobronchial and transbronchial biopsies in children.

Expert review of respiratory medicine, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.